Company record
BigHat Biosciences
Updated October 19, 2026 · Presspool
BigHat Biosciences designs protein therapeutics with a platform that pairs AI models with autonomous, high-throughput lab experiments. bighatbio.com
Funding
- $75 million Series C, announced September 24, 2026. Led by DFJ Growth and Premji Invest. Listed in the AI startup funding roster for September 21–26, 2026. Sources: BigHat Biosciences, BiopharmaTrend.
Of the 12 Series C rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, BigHat Biosciences' $75 million is the 11th largest; their median is $143 million.
Whether AI names BigHat Biosciences
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to October 18, 2026.
Related records
Closest rounds in the roster for September 21–26, 2026: Numeral ($100 million Series C, September 23, 2026), Basecamp Research ($140 million Series C, September 23, 2026), Noxtua (more than €100 million Series C, September 23, 2026), Firecrawl ($75 million Series B, September 22, 2026), Ema ($77 million Series B, September 23, 2026), Go.AI ($85 million Series A, September 22, 2026).
Premji Invest, which led this round, also led Clockwork.io ($31 million, round type not disclosed, October 5, 2026) and CScale ($145 million Series C, September 30, 2026).